Susquehanna International Group’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-245,105
| Closed | -$153K | – | 13197 |
|
|
2020
Q4 | $153K | Buy |
+245,105
| New | +$151K | ﹤0.01% | 10239 |
|
|
2020
Q2 | – | Sell |
-15,359
| Closed | -$12K | – | 11348 |
|
|
2020
Q1 | $12K | Buy |
+15,359
| New | +$21.1K | ﹤0.01% | 10026 |
|
|
2019
Q1 | – | Sell |
-32,371
| Closed | -$75.9K | – | 10269 |
|
|
2018
Q4 | $53K | Sell |
32,371
-13,901
| -30% | -$39K | ﹤0.01% | 8469 |
|
|
2018
Q3 | $224K | Buy |
46,272
+26,657
| +136% | +$151K | ﹤0.01% | 8017 |
|
|
2018
Q2 | $123K | Buy |
+19,615
| New | +$146K | ﹤0.01% | 8956 |
|
|
2018
Q1 | – | Sell |
-223,671
| Closed | -$2.14M | – | 10552 |
|
|
2017
Q4 | $2.28M | Sell |
223,671
-31,320
| -12% | -$301K | ﹤0.01% | 3674 |
|
|
2017
Q3 | $2.33M | Buy |
254,991
+196,589
| +337% | +$1.49M | ﹤0.01% | 3631 |
|
|
2017
Q2 | $426K | Buy |
+58,402
| New | +$441K | ﹤0.01% | 6937 |
|
|
2017
Q1 | – | Sell |
-24,821
| Closed | -$145K | – | 10403 |
|
|
2016
Q4 | $145K | Buy |
+24,821
| New | +$168K | ﹤0.01% | 8873 |
|
Susquehanna International Group's NEOS Position: Q1 2021 in Review
Susquehanna International Group sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 245,105 shares — an estimated $153K sold.
Susquehanna International Group first reported a position in NEOS in Q4 2016 and held it in 9 quarters. The position peaked at $2.33M in Q3 2017. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.
- Susquehanna International Group reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
- Susquehanna International Group sold 245,105 Neos Therapeutics, Inc shares in Q1 2021, an estimated $153K.
- Susquehanna International Group first reported a position in Neos Therapeutics, Inc in Q4 2016 and held it in 9 quarters.
- Susquehanna International Group's Neos Therapeutics, Inc position peaked at $2.33M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.
Based on Susquehanna International Group's 13F filing for Q1 2021, filed 17 May 2021.